Navigation
Navigation

Capital for Innovation, Impact and Growth

Capricorn Partners is an independent manager of private and quoted equity funds that invest in minority shareholding positions of innovative companies with technology as competitive advantage.

Venture Capital

Through our private venture capital funds, we invest in promising companies with technological advantages in sustainable chemistry, cleantech, health-tech, digital technologies and artificial intelligence. We are convinced that by investing in new technologies and innovations we can make a positive impact on our society and contribute to a better and more sustainable world, whilst achieving an acceptable return.

We support the growth of our portfolio companies as active value adding shareholders towards successful businesses and profitable exits.

Quoted Equity

Through our Quest Funds, we invest in best-of-class quoted and unquoted companies, managed by our dedicated team of specialists, focused on financial strength, growth prospects, market position, management strength and valuation.

Nexstim has placed an NBT® System with SmartFocus® technology to Stanford University Medical Center

News
- 14/10/2019

Helsinki, Finland: 14 October 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) – the company developing and marketing a unique brain stimulation technology for personalized treatment of major depressive disorder (MDD) – announces that it has placed…

Read more

BlueBee establishes data center in mainland China, expanding global coverage for its Genomics Data Platform

News
- 09/10/2019

Rijswijk, The Netherlands: 9 October 2019 – BlueBee, a global bioinformatics solutions provider, has extended data operations to mainland China to serve genomic data processing needs in compliance with The Chinese Ministry of Health and…

Read more

Mainstay Medical announces acceptance for filing by US FDA of Pre-Market Approval (PMA) Application for ReActiv8

News
- 01/10/2019

Dublin, Ireland: 1 October 2019 – Mainstay Medical International plc (Euronext Paris: MSTY.PA and Euronext Growth of Euronext Dublin: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable neurostimulation system to…

Read more